Episode 13: Jordan DeKraker Talks Seed Funding, Brain AI and Epilepsy

How can academic brain-imaging research become a practical clinical tool for people with drug-resistant epilepsy? In this episode of The Business of Neurotech, Adam Fraser is joined by Jordan DeKraker, co-founder and CEO of BrainScores and a postdoctoral researcher at the Montreal Neurological Institute, to discuss how he went from hippocampal mapping to building an AI-enabled neuroimaging company. In their conversation, Jordan talks about how his personal experience with epilepsy sharpened the company’s focus, what it takes to package open-source science into trustworthy software and why clinicians still need to stay in the loop. They also discuss early-stage funding, regulatory and market-entry decisions, interoperability, explainable AI and the wider role of precision imaging across neurotech. Tune in for a look at the business decisions behind bringing brain AI from the lab into clinical care with Jordan DeKraker.

Key Points From This Episode:

  • [01:21] Jordan’s path from hippocampal research to founding BrainScores.

  • [05:08] Find out what HippUnfold revealed and why its potential matters.

  • [07:25] Hear how Jordan’s epilepsy experience shaped the company’s first focus.

  • [12:05] Meet the co-founders and see how their skills support the company’s vision.

  • [13:43] Examine BrainScores’ non-dilutive funding and ambitions for venture capital.

  • [15:19] Understand the software as a medical device model and its go-to-market plan.

  • [17:46] Learn how BrainScores is testing the market and the role of feedback from clinicians.

  • [19:53] Uncover what the company hopes to achieve with its open-source platform.

  • [23:17] Understand why clinicians must remain accountable within an AI-assisted workflow.

  • [25:33] Whether healthcare AI should augment expertise rather than replace it.

  • [27:24] The model interoperability needed to integrate various data sources and tools.

  • [31:21] Compare funding, capital and opportunities between Canada and the US.

  • [34:45] Explore BrainScores’ roadmap beyond epilepsy into age-related cognitive decline.

  • [36:29] He shares his view on the future of BCI and transcranial stimulation.

  • [38:10] Where to follow Jordan’s research and the latest work from BrainScores.

Links Mentioned in Today’s Episode:

Jordan DeKraker on LinkedIn

The Neuro (Montreal Neurological Institute-Hospital)

BrainScores

BrainScores on LinkedIn

McGill University

HippUnfold

The Human Connectome Project (HCP)

Healthy Brains for Healthy Lives

Centre for Aging + Brain Health Innovation

Adam Fraser on LinkedIn

Omniscient Neurotechnology

The Business of Neurotech Podcast

Next
Next

Episode 12: Matt Angle Talks Paradromics and BCI Market Dynamics